|4Oct 2, 5:27 PM ET

NovaBay Pharmaceuticals, Inc. 4

4 · NovaBay Pharmaceuticals, Inc. · Filed Oct 2, 2013

Insider Transaction Report

Form 4
Period: 2013-09-26
Bley Keith R
SVP Product Development
Transactions
  • Award

    Option (right to buy)

    2013-09-26+51,000201,000 total
    Exercise: $1.71From: 2014-09-26Exp: 2023-09-26Common Stock (51,000 underlying)
Footnotes (2)
  • [F1]Options granted pursuant to 2007 Omnibus Incentive Plan
  • [F2]25% will vest on the first anniversary of the Grant Date. 6.25% will vest every three months thereafter

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    PRIMARY DOCUMENT